These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1762285)

  • 21. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races.
    Lucas GM; Lau B; Atta MG; Fine DM; Keruly J; Moore RD
    J Infect Dis; 2008 Jun; 197(11):1548-57. PubMed ID: 18422458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Projections of hypertension-related renal disease in middle-aged residents of the United States.
    Perneger TV; Klag MJ; Feldman HI; Whelton PK
    JAMA; 1993 Mar; 269(10):1272-7. PubMed ID: 8437305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial disparities in end-stage renal disease in a high-risk population: the Southern Community Cohort Study.
    Bock F; Stewart TG; Robinson-Cohen C; Morse J; Kabagambe EK; Cavanaugh KL; Birdwell KA; Hung AM; Abdel-Kader K; Siew ED; Akwo EA; Blot WJ; Ikizler TA; Lipworth L
    BMC Nephrol; 2019 Aug; 20(1):308. PubMed ID: 31390993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrepancy in the epidemiology of nondiabetic chronic renal insufficiency and end-stage renal disease in black and white Americans: the third National Health and Nutrition Examination Survey and United States Renal Data System.
    Trivedi HS; Pang MM
    Am J Nephrol; 2003; 23(6):448-57. PubMed ID: 14583664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.
    McClellan W; Tuttle E; Issa A
    Am J Kidney Dis; 1988 Oct; 12(4):285-90. PubMed ID: 3263042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.
    Brancati FL; Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    JAMA; 1992 Dec; 268(21):3079-84. PubMed ID: 1433738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.
    Li S; McAlpine DD; Liu J; Li S; Collins AJ
    Adv Ren Replace Ther; 2004 Jan; 11(1):5-13. PubMed ID: 14730534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes mellitus and hypertension: key risk factors for kidney disease.
    Lea JP; Nicholas SB
    J Natl Med Assoc; 2002 Aug; 94(8 Suppl):7S-15S. PubMed ID: 12152917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excess incidence of treatment of end-stage renal disease in Mexican Americans.
    Pugh JA; Stern MP; Haffner SM; Eifler CW; Zapata M
    Am J Epidemiol; 1988 Jan; 127(1):135-44. PubMed ID: 3276155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure, antihypertensive therapy and risk for renal injury in African-Americans.
    Kaperonis N; Bakris G
    Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):79-84. PubMed ID: 12496670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial differences in incidence, outcome, and quality of life for African-Americans on hemodialysis.
    Owen WF
    Blood Purif; 1996; 14(4):278-85. PubMed ID: 8873953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The familial risk of end-stage renal disease in African Americans.
    Freedman BI; Spray BJ; Tuttle AB; Buckalew VM
    Am J Kidney Dis; 1993 Apr; 21(4):387-93. PubMed ID: 8465818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors.
    Tarver-Carr ME; Powe NR; Eberhardt MS; LaVeist TA; Kington RS; Coresh J; Brancati FL
    J Am Soc Nephrol; 2002 Sep; 13(9):2363-70. PubMed ID: 12191981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. African American Study of Kidney Disease and hypertension (AASK)--clinical trial update.
    Agodoa L
    Ethn Dis; 1998; 8(2):249-53. PubMed ID: 9681290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.
    Hsu CY; Lin F; Vittinghoff E; Shlipak MG
    J Am Soc Nephrol; 2003 Nov; 14(11):2902-7. PubMed ID: 14569100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. End-stage renal disease and race: an overview and perspective.
    Ferguson R
    J Natl Med Assoc; 1991 Sep; 83(9):794-8. PubMed ID: 1942113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal disease in the inner city.
    Bakir AA; Dunea G
    Semin Nephrol; 2001 Jul; 21(4):334-45. PubMed ID: 11455521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.
    Costenbader KH; Desai A; Alarcón GS; Hiraki LT; Shaykevich T; Brookhart MA; Massarotti E; Lu B; Solomon DH; Winkelmayer WC
    Arthritis Rheum; 2011 Jun; 63(6):1681-8. PubMed ID: 21445962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory abnormalities at the onset of treatment of end-stage renal disease: are there racial or socioeconomic disparities in care?
    Ward MM
    Arch Intern Med; 2007 May; 167(10):1083-91. PubMed ID: 17533212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons from chronic renal diseases in African Americans: treatment implications.
    Agodoa L
    Ethn Dis; 2003; 13(2 Suppl 2):S118-24. PubMed ID: 13677426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.